Telmisartan
Also known as: Micardis
Angiotensin-receptor blocker used on cycle to keep blood pressure in check — favored for its long duration and studied metabolic side benefits.
Substance family
Medications for blood pressure, lipids and glucose. They appear here because these are exactly the markers most anabolic compounds push in the wrong direction.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
This substance works against
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
Blood-pressure control (on cycle)
AncillaryDose
20–80 mg / day
Frequency
1× / day
Cycle length
While blood pressure is elevated
Start low, titratetitrateAdjusting a dose stepwise against a measured result rather than setting it in advance. to actual blood-pressure readings; long half-lifehalf-lifeHow long it takes for half the substance to leave the body — it determines dosing frequency, not duration of effect. gives smooth 24 h coverage.
Overview
Telmisartan is an angiotensin-receptor blocker (ARB) — a well-tolerated blood-pressure medication. In the enhancement context it is used because many anabolic substances raise blood pressure (via water retention, higher hematocrit and vascular effects), and telmisartan's long duration makes it convenient.
Mechanism of Action
It blocks the angiotensin-II receptor, relaxing blood vessels and lowering blood pressure. Telmisartan is also studied for mild PPAR-gamma activity, which has drawn interest for metabolic side effects — though blood-pressure control is the primary use here.
Typical Context
Used on cycle when blood pressure trends high, alongside cardio and sensible water/sodium management. It is a genuine antihypertensive, not a supplement, and belongs under medical supervision.
Side Effects & Risks
- Dizziness, especially when starting or when blood pressure is already lower
- Elevated potassium in some people
- Caution with kidney impairment and certain drug combinations
Blood Work & Monitoring
- Blood pressure — the primary metric to titrate against
- Kidney function (eGFR, potassium) — before and during use
- General panel during longer use
Harm-Reduction Notes
- Actually measure blood pressure (home cuff) rather than guessing
- Cardio and controlling water/hematocrit address the root cause; medication is an adjunct
- Coordinate with a physician, especially if combining with other blood-pressure drugs
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Prescription-only medicineApproved for defined indications; use outside them is off-label. |
| EU / UK | Prescription-only medicineApproved for defined indications. |
| Canada / Australia | Prescription-only medicine |
| Parts of Asia, Latin America & Middle East | Pharmacy availability variesSeveral countries dispense it without prescription in practice. Rules and enforcement differ and change. |
| Competitive sport | Check the current WADA listSome substances in this class are prohibited, others are not. |